Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001387007 | SCV001587487 | pathogenic | Fetal akinesia deformation sequence 1; Congenital myasthenic syndrome 11 | 2023-02-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Cys97*) in the RAPSN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAPSN are known to be pathogenic (PMID: 17686188). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of congenital myasthenic syndrome (PMID: 14729848). ClinVar contains an entry for this variant (Variation ID: 1073877). |
Revvity Omics, |
RCV001780357 | SCV002019639 | pathogenic | not provided | 2019-08-20 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826172 | SCV002089167 | pathogenic | Congenital myasthenic syndrome | 2020-03-18 | no assertion criteria provided | clinical testing |